TP53 and cancer: Our findings revealed that the tumour‐prone cell populations across all lineages exhibited highly distinct signatures, which were associated with the oncogenic competence of these cell types to initiate cancer upon acquisition of the p53‐loss driver lesion (Figure S11A).